In Colorado, for example, the following conditions are state-approved for medical marijuana treatment:

• Cachexia (a condition typically caused by a disease like cancer or AIDS that causes significant weight loss, including muscle loss)
• Cancer
• Glaucoma
• HIV or AIDS
• Persistent muscle spasms
• Seizures
• Severe pain
• Post Traumatic Stress Disorder

Notice anything about that list? Except for PTSD, all of those conditions are primarily physical. 

The relationship between mental health and cannabis use is less clear. The U.S. drug war and decades of misinformation have biased the perception of cannabis use in mainstream medicine and culture.

Is Cannabis an Effective Treatment for Depression?

Thanks to nearly a century of federal cannabis prohibition making most plant studies illegal, there’s a lot about the cannabis plant that we just don’t know.

Study after study shows a correlation between cannabis use and depression, though prohibitionists or federal organizations sometimes use them to discourage cannabis use.

However, as more scientific studies are released and peer-reviewed by unbiased sources, it’s becoming increasingly clear that cannabis may be an effective treatment for the 280 million people in the world who suffer from depression.

Anecdotally, you can look at a longstanding cannabis review site like Leafly.com to see their database includes thousands of strains that users say positively affect depression and anxiety. Scientifically, recent studies released in The Journal of Biology and Medicine and Journal of Affective Disorders found that cannabis use provided great relief to those suffering from depression. 

There’s still plenty of work needed to get to the bottom of marijuana’s actual effects. But based on what we know now, here are five cannabis strains likely to help with symptoms associated with depression—like sadness, insomnia, a lack of energy, low concentration, and appetite loss.

Gelato

Cannabis enthusiasts prize the Gelato strain for its THC rate of 17% and uplifting effects. More than 2,000 people have ranked the strain at Leafly.com’s strain database—with “euphoric,” “aroused,” and “happy” being the top three good feelings they associate with it. 

About a quarter of Leafly’s reviewers said it aids in their depression (24%) and anxiety (26%), while 27% told the site that it’s a good destresser.

Photo: MmeEmil via gettyimages.com

Sherbert

If feeling relaxed, happy, and giggly sounds like a good alternative to your current mood, you’ll want to hit up your nearest dispensary for the Sherbert strain. 

“This strain exhibits powerful, full-body effects that are elevated by a jolt of cerebral energy and carefree state of mind,” Leafly’s in-house strain reviewers say. Its 18% THC rate “makes it an ideal choice for medical marijuana patients seeking relief from symptoms associated with stress, tension and mood disorders.”

Twenty-seven percent of users told Leafly that it helped with their anxiety and depression, respectively, while a whopping 35% said it’s a good stress reliever.

Thin Mint

Thirty percent of Leafly’s users told the company that the Thin Mint strain aids their depression, while 35% said it is a good destresser and 26% said it helps with pain—that’s a medical trifecta. It’s also a trifecta in a different sense, as the strain itself is a cross between sativa Durban Poison, indica OG Kush, and hybrid strain GSC (“Girl Scout Cookie”).

“Uplifted,” “euphoric,” and “relaxed” were users’ three highest-ranked feelings.

Dosidos

If you think you’re noticing a food theme here when it comes to strain names, welcome to the world of cannabis! And let’s talk about eating. Of course, cannabis is famous for its “munchy” effects, but some strains are more potent than others when creating an appetite. 

And being that a lack of appetite can be a sign of depression, what better solution than a strain known for making people hungry? And when “sleepy” and “relaxed” are the other two highest-ranking feelings in the Leafly database, it must be time to grab yourself an eighth of Dosidos.

Skunkberry

No mood-altering list of cannabis strains would be complete without a skunk on it. Yes, the skunk strains are known for smelling like, well, a skunk. They’re also famous for their euphoric and simultaneously pain-relieving high. 

At Leafly’s database, “relaxed,” “euphoric,” and “happy” were the highest-ranked feelings for the Skunkberry strain. About a third of reviewers told the website that Skunkberry helps with pain, stress, and depression. 

The next time you’re feeling a bit down, you might find some relief in alleviating your depression symptoms with one of these top-rated strains.

REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has executed an asset purchase agreement (“Agreement”) dated January 11, 2022, to acquire a Ketamine clinic located in Jacksonville, Florida (“Acquisition”). Revitalist had previously announced the Acquisition non-binding letter of intent on October 27, 2021. This Acquisition represents the ninth clinic for the Company and is expected to commence under the Revitalist brand by February 1, 2022. The Jacksonville clinic was formed in 2017 and continues to be managed by Dr. Nicholas Kalynych who has over 30 years of experience in health care.

Dr. Nicholas Kalynych commented: “I am very pleased to be teaming up with Revitalist to accelerate growth of the practice in Jacksonville. With this acquisition complete, we are now positioned to significantly expand our service offerings and patient count, which will provide the Jacksonville community greater access to care.”

Kathryn Walker, CEO of Revitalist, commented: “With the closing of this acquisition, Revitalist will have nine clinics operating in six states. We are well on our way to executing our growth plans. On behalf of the entire company, I would like to formally welcome Dr. Kalynych and his team to Revitalist. We look forward to implementing our business model in Jacksonville and utilizing the decades of experience provided by Dr. Kalynych to offer exceptional treatments to the community.”

Pursuant to the terms of the Agreement, the consideration for the Acquisition is $100,000 USD. The consideration payable is $60,000 USD in cash and $40,000 in common shares. The share consideration will be issued at the greater of $0.50/share and the 20-day volume weighted average share price preceding the issue date and will be issued 50% in 12 months and 50% in 24 months following the closing of the Acquisition.

ABOUT REVITALIST LIFESTYLE AND WELLNESS LTD.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with seven clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here .

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

On Behalf of the Board:
Kathryn Walker
Chief Executive Officer

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.

Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220112005347/en/

For further information:
Revitalist Lifestyle and Wellness Ltd.
Email: [email protected]
Tel: (865) 585-8414

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

By Rebecca Olmos | TheCannifornian.com Correspondent

As cannabis becomes more of a mainstream substance, known for its potential medicinal benefits, many people have turned to it as a means of coping with symptoms of different reasons like sleep, pain, and even mental health conditions like stress, anxiety, and depression.

What is depression?

Depression, or major depressive disorder, is a mental condition that negatively affects how you think, feel and act. According to the World Health Organization (WHO), depression affects over 280 million adults worldwide. Symptoms of depression include but are not limited to feelings of sadness, loss of interest in everyday activities, low energy, changes in appetite, and random sleeping patterns.

It’s important to note that if you’re experiencing these symptoms, you should first speak with a trained medical professional or counselor. This article is only meant to provide insight into the current understandings between cannabis and depression.

Our endocannabinoid system, mental health, and cannabis

Our endocannabinoid system (ECS) links cannabis and our mental health. The complex system of neurotransmitters and receptors is responsible for helping the body maintain homeostasis for various functions, including cognitive ones like emotions and behavior.

According to Harvard Health, there are many reasons a person could experience depression — faulty mood regulation by the brain, traumatic events, medications, and chronic stress. Researchers at the University of Boston found that chronic stress significantly reduced the production of endocannabinoids in the animals they studied. They are looking to cannabis to help restore those levels.

Phytocannabinoids, like tetrahydrocannabinol (THC), are found in the cannabis plant. They have a similar structure to one of the body’s naturally occurring endocannabinoids, anandamide. It is coined the “bliss molecule” because of its role in mental wellness and motivation. Studies have also shown that THC stimulates the body to release dopamine which is responsible for feelings of pleasure and satisfaction.

Things to consider when choosing a cannabis product to help with mental health

Cannabis is a biphasic molecule which means the effects you may experience depend on the size of the dosage. In small doses, a person may experience relaxing feelings. In high doses, it might induce anxiety, so it is always best when experimenting with cannabis to start low and go slow.

There is currently no research done to support the clinical usage of cannabis for depression. Still, there are a few studies that show the antidepressant effects of the phytocannabinoid cannabidiol, CBD. Small doses of CBD-rich products might be a good starting point when beginning a journey to infuse cannabis into a mental health and wellness routine.

Sleeping problems are common, and anyone can be a victim of sleep disorders. About 70 percent of both children and adults cannot sleep the recommended hours in a day. Even though significant causes of sleep deprivation are hectic schedules and stress, medical and mental health problems may deprive you of a good night of sleep. Lack of enough sleep may negatively impact your overall health, cause poor concentration, mood changes, and lack of motivation.

It is crucial to consult or seek medical help when you suspect you have a sleeping disorder. Even though some medications may help you get a quick and lengthy nap, natural treatment options are always a good choice. CBD is one of these natural regimens that could help you have a restful and relaxed night of sleep.

What is Cannabidiol (CBD)?

CBD is one of the major cannabinoids in the cannabis plant – Hemp. CBD targets your endocannabinoid system (ECS), influencing homeostatic processes. The ECS is responsible for regulating and balancing various body processes, including immune responses, cell communication, appetite and metabolism, memory and many other responses as well.

Unlike Tetrahydrocannabinol (THC), CBD does not have a “high” effect on its users. However, it has several beneficial health benefits that have taken over the medical world by storm. Research shows CBD can be an effective remedy in the treatment of anxiety and depression. Besides, it can also help in alleviating pain and reduce inflammation. Further research and anecdotal evidence also show that CBD is useful in treating insomnia and other sleep disorders.

Does CBD help sleep better?

To understand how CBD improves sleep, we must first understand what leads to poor sleeping habits. Common causes of insomnia include:

• Lack of a conducive environment for sleep, such as loud neighborhoods, uncomfortable bedding, or intrusive lighting among other factors as well.
• Physical conditions that cause discomfort or chronic pain, e.g., restless muscles, body injury, headaches, and many more issues that may exist.
• Caffeine consumption at night.
• Medication that interrupts the sleep cycle
• Mental health disorders; these could include anxiety, depression, post-traumatic stress disorder (PTSD), and psychosis.

CBD research is still in its preliminary stages and a lot is yet to be understood on how CBD works. Anxiety is the root cause of many sleep disorders. The mind simply cannot be calm enough to allow the sleep process to take over.

In 2019, research was conducted to analyze the benefits of CBD vape oil on sleep and anxiety reduction. 72 subjects took 25mg of CBD per day and 79.2% of them reported lower anxiety levels, while 66.7% claimed they slept better after taking the medication. This serves as hard evidence that CBD can be useful in treating sleep disorders.

Can CBD help alleviate pain?

CBD also shows potential for alleviation of pain. Evidence indicates that CBD soothes pain, which in the long run serves to improve sleeping patterns. We all know or have experienced the discomfort pain can cause and the effects on your sleeping patterns. CBD has analgesic properties that are known to help alleviate pain. Some people with sleeping disorders, especially those with Schizophrenia, may experience nightmares, forcing them to stay awake. CBD can help them sleep better by improving REM Sleep Behavior Disorder (RBD), a sleep disorder whereby the patient acts out their dreams.

Taken in various doses, CBD can display sedative properties. This is important when treating insomnia as it can help to calm the mind, thus inducing sleep. Such interaction enables the patient to develop a healthy sleep-wake cycle.

How does CBD work to help with sleep?

As discussed earlier, CBD influences the functions of the ECS. CBD is known to reduce cortisol levels in the body. Cortisol is also known as “the stress hormone.” Furthermore, CBD has anxiolytic and antipsychotic properties. Once consumed, it can calm the user by reducing cortisol levels and inhibiting the metabolism of anandamide. High anandamide levels in the body result in higher psychosis tendencies in schizophrenic patients. If you are experiencing night-time awakening, especially when suffering from schizophrenia, CBD can offer a sedative effect and this can help you sleep better for longer hours.

CBD Dosage for Sleep

There is no specific rule when it comes to CBD dosage. However, small doses of CBD have stimulating effects, while a higher dose can have sedative effects. You should choose the amount of CBD depending on the severity of your sleeping problems. A general rule for taking cannabidiol is starting with a lower dose and increasing the amount gradually. As a result, you will understand how your body tolerates varying amounts of CBD doses.

Consequently, insomnia also disrupts the sleep-wake cycle. When a user consumes CBD in relatively higher doses, it can induce a sedative effect. This is helpful as CBD helps induce sleep. However, experts say that 40mg-80mg is a proper dosage to treat sleep disorders. Some doctors prescribe a dosage as high as 300mg per day.

Conclusion

Insomnia is a common ailment facing almost half of the general population at some point in their lives. You have to admit that you have experienced sleepless nights now and then. Many people are now trying out CBD for their sleeping problems. It is generally safe and improves sleep duration, and balances out the sleep-wake cycle. Over time, people have established CBD usage for various reasons, including reducing seizures, anxiety, and pain. Sleep treatment is now a relative discovery that is dominating the medical scene. Proper and clear-cut dosage levels are yet to be established since research is still underway. However, lower doses induce stimulant effect

Whether it’s relieving anxiety and depression or providing a better alternative to melatonin to combat insomnia, there’s no shortage of the physical and mental benefits provided by CBD. However, understanding the difference of CBD verses CBD with THC is something you should know.

As you’re perusing CBD products online or in brick and mortar stores, you may notice that some items contain various amounts of THC. Should you consider these options, and what are the pros and cons?

Let’s get down to brass tacks to give you an understanding of standalone CBD products versus CBD with THC options.

CBD: What You Need to Know

If you’re new to the world of cannabidiol, let’s quickly clear up some misconceptions. Unlike its THC counterpart, CBD is not a psychoactive agent providing a “high” sensation. It’s extracted from cannabis plants, often diluted with coconut or hemp seed oil, and can provide relief for everything from muscle soreness to cancer medication side effects.

Your dog can even take it.

In a nutshell, CBD “supports the natural neurotransmitter in our bodies. CBD binds to a receptor that triggers serotonin release leading to a reduction in stress and anxiousness, which balances moods.”

CBD is legal in the United States, so it’s perfectly kosher to have it shipped to your doorstep or purchased at major retailers like Whole Foods. You can even travel with it domestically.

The benefits of cannabidiol can’t be overstated, but what about CBD items possessing THC as well?

CBD with THC: What You Need to Know

CBD products with THC should be treated differently than CBD-only items.

Depending on how much THC is in each product, you could find yourself relatively “high,” euphoric, or sleepy, making the CBD-THC combo ideal for falling asleep or back to sleep.

It can also be an excellent way to unwind at the end of the day, similar to a glass of red wine (but without the unwanted calories and red teeth).

CBD with THC can also provide a one-two punch considering research has shown they both help with anxiety, nausea, and various types of pain and discomfort.

There are a few issues to keep in mind if you decide THC with CBD is right for you. Cannabinoids store in your body fat so that the THC can show up on potential drug tests, which could cost you your job depending on your state’s laws.   

You’ll also want to adhere to the cannabis maxim of “You can always have more, but you can never have less.” That is to say, start with a minimal amount versus eating a 50-milligram chocolate bar right out of the gate. Not sure how many milligrams to begin with? Consult your doctor, and dispensaries always have experts to assist you online, over the phone, and in the store.

Most importantly, it’s critical to check your state laws regarding THC products of any amount because what’s perfectly legal in one state could be highly illegal in another.

Cannabis has been used for thousands of years. From native Indians to various subcultures, people have used cannabis for several reasons. However, there has always been a stigma surrounding cannabis use. Although a lot of people used the plant, it was never widely accepted by the general public.

However, things started changing in the last 40 years. Today there are many countries in which medical cannabis is legal, and there’s tons of research about this plant and its benefits. This change is obvious for another reason as well, currently there are thousands of medical dispensaries where people can legally buy cannabis.

For example, residents of California can drop by Venice Beach cannabis dispensary and instantly get cannabis for their needs. One of the reasons these medical dispensaries are so popular is because they promote responsible cannabis use. Here’s how they work.

They Offer Better Product Quality

In the past, people had to get cannabis from unreliable sources and shady channels. Simply put, there wasn’t a legal way to get marijuana, which made it difficult to find quality products along with a reliable source they could always count on.

It was also very unsafe. People had issues because they often bought low-quality products with no guarantee of what they were getting. People had to trust that the seller would deliver good quality. Today, products at medical dispensaries come from professional breeders and cultivators.

Customers know the exact strain they are getting and these producers are held to a higher standard. Simply put, they need to pass various quality checks to be able to sell their products.

They are Safer

Using cannabis responsibly is not just about having a reliable supplier – the way you get your products matters as well. Whenever illegal production and supply are involved, there are certain risks for everyone, including consumers.

As a buyer you don’t want to meet someone in the back alley, not knowing what to expect. You can potentially get robbed, scammed or even arrested if cannabis is illegal. Medical dispensaries are far safer. First of all, the cannabis they sell is completely legal and legit.

You don’t have to worry about being scammed. You can just drop by and purchase the product you need. At the same time, dispensaries often have security personnel and cameras that protect you from potential criminals.

You Know What You are Getting

Dispensaries must be transparent. What does this mean? A couple of things:

• Every medicine and product that’s being sold goes through rigorous checks.
• The origin of each product can be traced back to the producer.
• Product packaging clearly states the content of the product and all its ingredients.
• If you have additional questions, you can talk to the pharmacist working at the dispensary

When buying medical products you need to know what they contain, since people use cannabis for treating different conditions. Professional producers breed different strains that are better at alleviating various symptoms.

For example, some marijuana strains are better for treating depression and anxiety while others might be better for arthritis. You can always find a product that’s best for your needs.

Dispensaries Can Educate Users on Proper Cannabis Use

Dispensaries often have medical professionals working at them. These pharmacists are there to accept various medical forms and prescriptions that people use to get their medical products. However, there is another advantage of having medical professionals at the dispensary.

They have a lot of knowledge about different medications, how they work, and how they should be used. So, you’re not buying cannabis products from a random person – you’re getting it from people who have a medical background.

They can give you valuable advice on how to use your medicine properly, which is especially important when you’re taking cannabis for the first time and don’t know what to expect. A pharmacist can help you understand how you should use your medicine, when, and in what dosage.

Chances are you’ve heard about various cannabis side-effects, but in reality most of them are caused by improper use. People take high doses in uncontrolled environments and they suffer the consequences. A medical professional can guide you to avoid this from happening.

Bottom Line

The use of cannabis for medical purposes has gone a long way. All over the world, we are seeing more and more countries letting people treat several conditions with this medication. At the same time, we are also seeing an increase in cannabis-based drugs.

Dispensaries have made supply a lot easier to obtain. They make these products available to everyone who has an appropriate medical prescription. At the same time, people can use cannabis responsibly to get the desired effects.

From life-threatening viruses to raging wildfires to skyrocketing unemployment, 2020 is testing the human spirit in unimaginable ways. One such symptom of this year’s chaos is maintaining proper mental health as bad news continually wafts through televisions sets like a skunk’s scent from a bedroom window.

Anxiety and depression are running amok. Some studies discovered that “In mid-July, 53% of adults in the United States reported that their mental health has been negatively impacted due to worry and stress over the coronavirus. This is significantly higher than the 32% reported in March.”

With so much uncertainly swirling about, how are CBD, anxiety and depression intertwined, and how can cannabidiol products help during such trying times?

CBD and Anxiety

In 2011, a study reported that CBD possessed the power to reduced anxiety during public speaking for those anxious in social situations. How was that possible?

CBD aids the neurotransmitters already bouncing around your brain by promoting the release of serotonin. It’s a potential alternative to sketchy “happy pills” like Prozac, and you can purchase it at outlets as popular as Whole Foods.

No grocery stores in your area with CBD items? No worries. Products are legal to ship to your doorstep in the United States.

CBD and Depression

CBD can help with depression, similar to relieving anxiety issues. Early studies on canines and CBD showed great promise in raising low serotonin levels.

Science has only progressed in purporting that CBD has incredible antidepressant effects, but it’s always smart to speak with your doctor about your unique situation, including how many milligrams to begin with and any potential side effects.

Say Goodbye to Insomnia

Pandemic or not, you know full well how difficult everyday tasks are following a night of fitful sleep, and a lack of solid slumber can exasperate anxiety and depression.

To maximize your chances of saying goodnight to insomnia, check out products consisting of tinctures easily added to evening teas, soothing bath salts, yummy edibles (don’t worry, no THC here) and more.

In Sickness and in Health

Whether you’re battling a life-threatening disease, anxiety and depression or simply looking to feel your best, CBD helps in additional ways:

• Reduces pain and inflammation
• Can help increase the lack of appetite often arising from anxiety or depression
• Exercise is closely linked to alleviating anxiety and depression. CBD can provide muscle recovery afterward
• Offers a viable alternative to traditional drugstore items unhelpful in providing relief
• Confidence in knowing products are legal and regulated
• Depending on where you live, home delivery is possible

These are challenging times, to say the least, and we aren’t clear of the forest yet, but with an assist from over-the-counter CBD items, you can increase your odds of keeping anxiety and depression at bay.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as “expects”, “will”, “anticipates”, and “estimates”; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief “snapshot” of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled “Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

A big factor in the recent rise of cannabis legalization is the emergence of legitimate scientific research into the potential health benefits of the plant’s active ingredients, called cannabinoids. Medicines are often derived from naturally occurring compounds, from aspirin to insulin to penicillin. A decent body of research is currently pointing to psilocybin, the psychedelic active ingredient in some types of mushrooms, as well as other psychedelics like LSD, as the next big natural drug discovery. Researchers are in various stages of studying the effect of psychedelics on conditions ranging from depression to addiction to migraines to anxiety and more. It might be time to pay attention to the field as more researchers test the therapeutic potential of psychedelics.

One company certainly paying attention is EHave, Inc. (OTC: EHVVF). The company has developed a technology platform that helps doctors and patients make data-informed treatment decisions for a variety of mental health indications. With the formation of a subsidiary called Mycotopia Therapy and an initial acquisition of PsychedeliTech, the company is becoming a major player in the emerging psychedelic medicine space. The Ehave Dash, already HIPAA and GDPR compliant, will be used as a central clearinghouse for psychedelic research data and clinical trial tracking with the intent to further advance the science of psychedelic therapies.

Psychedelic Research Enters the Mainstream

Just last year, the Johns Hopkins School of Medicine opened the Center for Psychedelic and Consciousness Research in Baltimore. Headed by renowned researcher Roland R. Griffiths, Ph.D., the Center aims to further research the school has already been conducting. Initial areas of focus include potential therapies for opioid addiction, Alzheimer’s disease, PTSD, and anorexia among other conditions. Johns Hopkins researchers have been pioneers in the field as the first researchers, in 2000, to get US regulatory approval for the use of psychedelics in health volunteers. Since then, the school’s researchers have published more than 60 peer-reviewed studies and demonstrated safe practices for psychedelic research that have set the standard for other studies across the world.

There are plenty of other researchers pursuing potential psychedelic therapies. The University of Toronto Mississauga recently started a Psychedelic Studies Research Program. The British Columbia Centre on Substance Abuse is launching a Phase III clinical trial of MDMA as a treatment for PTSD, in conjunction with 16 other locations throughout North America and Israel, and funded by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS). The MAPS site has comprehensive lists of research, both ongoing and completed, conducted by MAPS as well as other organizations. There is a lot of scientific interest in psychedelics, and it is growing exponentially.

EHave’s Plan

The PsychedeliTech acquisition is just the first step for EHave in a comprehensive plan to bring together the diverse and scattered research (and researchers) into one collaborative platform. PsychedeliTech is hosting the inaugural PsyTech Summit March 29-30, in Tel Aviv, Israel. Modeled after the hugely successful CannaTech conference, a global gathering for the cannabis industry. In fact, PsychedeliTech is a subsidiary of Israel Cannabis Limited (iCAN), the creator of the CannaTech conference, and the two conferences run back-to-back at the same location this year. 

The goal of the PsyTech Summit is to elevate the psychedelics conversation, foster normalization, and accelerate innovation. Why is EHave acquiring the company and the conference? Because its subsidiary, Mycotopia Therapy, was founded to work toward the same goals. EHave believes its EHave Dash platform can play a crucial role in the worldwide advancement of psychedelic research. The Dash is HIPAA and GDPR compliant, meaning that the data carried by the Dash is totally secure and in line with the world’s most strict privacy and security rules. The idea is to compile all psychedelic research and results in the EHave Dash, providing valuable and easily accessible information for scientists across the globe as they pursue their own studies.

The PsyTech Summit is a perfect vehicle for fostering crucial relationships with innovators in the space. It could also serve to introduce Mycotopia Therapy to other potential investments or acquisitions that fit under the company’s mission, as the PsyTech acquisition is just the first of many moves to come.

The Upshot

The story of psychedelics as therapeutic treatments is now unfolding across the world. There is a lot of promising research into a wide variety of problematic neurological and psychological conditions that have resisted more traditional treatments to date. It’s a potentially explosive industry in its infancy, and EHave is making moves to become a key cog in the industry’s development. Keep an eye out here for more news regarding both the company and the movement in general.

Please click here for additional Information on EHave, Inc. (OTC: EHVVF)

Please click here for additional Information on Mycotopia Therapy

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.